483 Roundup: FDA Cites Seven Firms for GMP, Quality Lapses By Sam | March 3, 2020 The FDA hit drugmakers in China, South Korea, India and Germany for numerous GMP and other violations observed during agency inspections. Source: Drug GMP Report Posted in Drug GMP Report